Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Robbins

Showing results (171-180 of 258) with videos related to

Pageof 26
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1Christopher E Touloukian, Wolfgang W Leitner, Rhonda E Schnur, et al.
Cancer|January 1, 1978
Immunologic reactivity in patients with primary operable breast cancerH J Wanebo, H T Thaler, J A Hansen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapyPaul F Robbins, Mark E Dudley, John Wunderlich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1995
Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1L Rivoltini, Y Kawakami, K Sakaguchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Changes in the fine specificity of gp100(209-217)-reactive T cells in patients following vaccination with a peptide modified at an HLA-A2.1 anchor residueT M Clay, M C Custer, M D McKee, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancerJeffrey Chou, Lilien N Voong, Christie L Mortales, et al.
Human Gene Therapy|July 9, 2014
A human ErbB2-specific T-cell receptor confers potent antitumor effector functions in genetically engineered primary cytotoxic lymphocytesEvripidis Lanitis, Jenessa B Smith, Denarda Dangaj, et al.
The Journal of Antibiotics|April 13, 2017
Heterologous expression of diverse propionyl-CoA carboxylases affects polyketide production in Escherichia coliGergana A Vandova, Robert V O'Brien, Brian Lowry, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 1994
Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejectionY Kawakami, S Eliyahu, C H Delgado, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2008
Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapyKhoi Q Tran, Juhua Zhou, Katherine H Durflinger, et al.
Pageof 26

Showing results (171-180 of 258) with videos related to

Sort By:
Pageof 26
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1Christopher E Touloukian, Wolfgang W Leitner, Rhonda E Schnur, et al.
Cancer|January 1, 1978
Immunologic reactivity in patients with primary operable breast cancerH J Wanebo, H T Thaler, J A Hansen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapyPaul F Robbins, Mark E Dudley, John Wunderlich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1995
Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1L Rivoltini, Y Kawakami, K Sakaguchi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 1999
Changes in the fine specificity of gp100(209-217)-reactive T cells in patients following vaccination with a peptide modified at an HLA-A2.1 anchor residueT M Clay, M C Custer, M D McKee, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancerJeffrey Chou, Lilien N Voong, Christie L Mortales, et al.
Human Gene Therapy|July 9, 2014
A human ErbB2-specific T-cell receptor confers potent antitumor effector functions in genetically engineered primary cytotoxic lymphocytesEvripidis Lanitis, Jenessa B Smith, Denarda Dangaj, et al.
The Journal of Antibiotics|April 13, 2017
Heterologous expression of diverse propionyl-CoA carboxylases affects polyketide production in Escherichia coliGergana A Vandova, Robert V O'Brien, Brian Lowry, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 1994
Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejectionY Kawakami, S Eliyahu, C H Delgado, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2008
Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapyKhoi Q Tran, Juhua Zhou, Katherine H Durflinger, et al.
Pageof 26